Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001564590-19-011852
Filing Date
2019-04-17
Accepted
2019-04-17 16:48:46
Documents
3
Period of Report
2019-05-30
Effectiveness Date
2019-04-17

Document Format Files

Seq Description Document Type Size
1 DEF 14A flgt-def14a_20190530.htm DEF 14A 548612
2 GRAPHIC gmwfgdgrqkww000002.jpg GRAPHIC 74315
3 GRAPHIC gmwfgdgrqkww000001.jpg GRAPHIC 62988
  Complete submission text file 0001564590-19-011852.txt   739103
Mailing Address 4978 SANTA ANITA AVENUE, SUITE 205 TEMPLE CITY CA 91780
Business Address 4978 SANTA ANITA AVENUE, SUITE 205 TEMPLE CITY CA 91780 626-350-0537
Fulgent Genetics, Inc. (Filer) CIK: 0001674930 (see all company filings)

EIN.: 812621304 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37894 | Film No.: 19753476
SIC: 8071 Services-Medical Laboratories